Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Compass Therapeutics
Mayo Clinic
Mayo Clinic
ViroMissile, Inc.
Eisai Inc.
Children's Oncology Group
Seagen Inc.
SEED Therapeutics, Inc.
Essen Biotech